Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
World Vitiligo Map
Your guide to the vitiligo community worldwide. Use the selector to filter by patient support groups, specialists, research centers, clinical trial locations, or World Vitiligo Day events.
Directory Information & Disclaimer
This free public directory gathers information from public sources to help connect our global community. Medical professionals and organizations listed are independent and not affiliated with or endorsed by the Vitiligo Research Foundation (VRF), and no fees are accepted for listings.
Because clinics, support groups, and specialists move or update their services over time, some information may occasionally become outdated. As a result, VRF cannot guarantee the complete accuracy or usefulness of listed third-party resources.
Help Us Keep the Map Accurate
Do you need to add a listing, update outdated details, or request a removal? Please reach out to us using the feedback form on our Contact Us page.
Search Map
44 records found for “NCT07047612” · show all
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, 400016, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoZhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoWuhan NO.1 Hospital(Wuhan Hospital of Traditional Chinese and Western Medicine), Wuhan, Hubei, 430022, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoShandong First Medical University Affiliated Dermatology Hospital (Shandong Institute of Dermatology and Venereology, Shandong Dermatology Hospital), Jinan, Shandong, 250022, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoQilu Hospital of Shandong University, Jinan, Shandong, 250012, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, 241001, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoPeking University Third Hospital, Beijing, Beijing Municipality, 100191, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoBeijing Chao-yang Hospital,Capital Medical University, Beijing, Beijing Municipality, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoBeijing Tongren Hospital, Beijing, Beijing Municipality, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoChongqing Traditional Chinese Medicine Hospital, Chongqing, Chongqing Municipality, 400021, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoUnion Hospital affiliated to Fujian Medical, Fuzhou, Fujian, 350001, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoSun Yat-sen Memorial Hospital,Sun Yat-sen University, Guangzhou, Guangdong, 510120, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoDeramatology Hospital of Southern Medical Univercity, Guangzhou, Guangdong, 516006, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoNanyang First People's Hospital, Nanyang, Henan, 473000, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoThe First Affiliated Hospital of Xinxiang Medical College, Weihui, Henan, 453100, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoHenan Provincial People's Hospital, Zhengzhou, Henan, China
021-52887775
- ICP-332 in Subjects With Non-segmental Vitiligo
Phase: PHASE2, PHASE3
Intervention: Drug: ICP-332 Tablets; Drug: ICP-332 Placebo Tablets
Status: Open now
Organizer: Beijing InnoCare Pharma Tech Co., Ltd.
Trial page: https://vrfoundation.org/trials/icp-332-tablets-for-nonsegmental-vitiligoJingzhou Central Hospital, Jingzhou, Hubei, 434020, China
021-52887775
FAQOther Questions
- Shall I take vitamin D for my vitiligo?
Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be ideal for mo...
- How to get insurance coverage for vitiligo treatments?
Getting insurance coverage for vitiligo treatments can be challenging, but there are several steps you can take to improve your chances For a more in-depth look, check out our u...
- What are the best predictors for therapy response in vitiligo?
A fair question. Also a slightly annoying one, because dermatology loves nuance and patients usually want something more like a weather forecast. Still, a few factors do show up...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.